| Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005) (NCT05443841) | Fudan University | 2022-07-18 |
| FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) (NCT05432193) | POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | 2022-07-13 |
| Project CADENCE (CAncer Detected Early caN be CurEd) (NCT05633342) | MiRXES Pte Ltd | 2022-07-07 |
| Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy (NCT05817201) | Taizhou Hospital | 2022-07-01 |
| Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 (NCT05383482) | Laekna Limited | 2022-07-01 |
| Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection (NCT05517811) | University of Colorado, Denver | 2022-06-26 |
| Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors (NCT05538195) | Chongqing Precision Biotech Co., Ltd | 2022-06-07 |
| To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence (NCT05376423) | National Taiwan University Hospital | 2022-06-02 |
| The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy. (NCT06019455) | Sun Yat-sen University | 2022-06-01 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| Comparison of Subtotal Stomach and Narrow Gastric Tube After Esophagectomy (NCT05342805) | University Medical Center Ho Chi Minh City (UMC) | 2022-05-03 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc (NCT05604664) | Yongtao Han | 2022-05-01 |
| PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy (NCT05055648) | University of Aarhus | 2022-05-01 |
| NIF-Guided RAMIE Using ICG Versus OTE Feasibility RCT (NCT04938973) | St. Joseph's Healthcare Hamilton | 2022-05-01 |
| Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy (NCT06061263) | Sun Yat-sen University | 2022-05-01 |
| Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection (NCT05460403) | Chinese Academy of Medical Sciences | 2022-04-23 |
| A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors (NCT05070247) | Takeda | 2022-04-14 |
| The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III (NCT04871412) | Ottawa Hospital Research Institute | 2022-04-04 |
| ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer (NCT05245760) | Zhonglin Hao | 2022-04-01 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery (NCT05145647) | Chang Gung Memorial Hospital | 2022-03-30 |
| Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies (NCT05462314) | Viome | 2022-03-29 |
| Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer (NCT05183126) | University of Michigan Rogel Cancer Center | 2022-03-28 |
| Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer (NCT05192460) | jianming xu | 2022-03-28 |
| Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer (NCT05412628) | National Cheng-Kung University Hospital | 2022-03-15 |
| Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors (NCT05169437) | Tempus AI | 2022-03-15 |
| TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer (NCT05188313) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2022-03-09 |
| Non-endoscopic Esophageal Sampling to Detect Barrett's Esophagus and Esophageal Cancer in Veterans (NCT05210049) | Louis Stokes VA Medical Center | 2022-03-01 |
| Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves During Thoracoscopic Esophagectomy (NCT05199168) | Tianjin Medical University Cancer Institute and Hospital | 2022-03-01 |
| Resilience and Equity in Aging, Cancer, and Health (REACH) (NCT04674267) | Dana-Farber Cancer Institute | 2022-01-18 |
| AN0025 and Chemoradiotherapy Combination in Esophageal Cancer (NCT05191667) | Adlai Nortye Biopharma Co., Ltd. | 2022-01-18 |
| A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC (NCT05182944) | The First Affiliated Hospital of Zhengzhou University | 2022-01-15 |
| A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies (NCT06997302) | Tianjin Medical University Cancer Institute and Hospital | 2022-01-01 |
| Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer (NCT04654403) | The First Affiliated Hospital of Zhengzhou University | 2022-01-01 |
| A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer (NCT05183958) | Zhejiang Cancer Hospital | 2021-12-31 |
| Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer Surgery (NCT03587532) | University Hospital, Ghent | 2021-12-13 |
| A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study (NCT06290505) | Australasian Gastro-Intestinal Trials Group | 2021-12-08 |
| Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell (NCT05049681) | Feng Wang | 2021-12-05 |
| VITAMin Insufficiency in Esophagogastric Neoplasms (NCT05281380) | Zuyderland Medisch Centrum | 2021-12-01 |
| Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer (NCT04390945) | The First Affiliated Hospital of Henan University of Science and Technology | 2021-12-01 |
| Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy (NCT05105945) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2021-11-11 |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors (NCT05187338) | Second Affiliated Hospital of Guangzhou Medical University | 2021-11-01 |
| Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy (NCT04846309) | University of Utah | 2021-10-12 |
| The Registry Study of Genetic Alterations of Esophageal Cancer in Taiwan (NCT04996095) | National Health Research Institutes, Taiwan | 2021-10-01 |
| ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) (NCT04752358) | Adaptimmune | 2021-09-15 |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors (NCT05415475) | Chongqing Precision Biotech Co., Ltd | 2021-09-10 |
| Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients (NCT05030870) | RenJi Hospital | 2021-09-01 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| A Study of PRT1419 in Patients With Advanced Solid Tumors (NCT04837677) | Prelude Therapeutics | 2021-08-11 |
| Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer (NCT04984096) | Shanghai Chest Hospital | 2021-08-01 |
| Migration Rates of Sutured vs Non-sutured Esophageal Stent Placement (NCT05082948) | West Virginia University | 2021-07-20 |
| Anlotinib for Esophageal Cancer (AFEC) (NCT04966611) | Anyang Tumor Hospital | 2021-07-15 |
| Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (NCT05007613) | National Taiwan University Hospital | 2021-06-23 |
| Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer (NCT04871204) | Fredrik Klevebro | 2021-06-16 |
| Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) (NCT04498767) | European Organisation for Research and Treatment of Cancer - EORTC | 2021-06-10 |
| Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NCT04913337) | NGM Biopharmaceuticals, Inc | 2021-06-09 |
| Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study (NCT04843397) | University of Cambridge | 2021-06-01 |
| AB122 Platform Study (NCT04999761) | Taiho Pharmaceutical Co., Ltd. | 2021-06-01 |
| Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical Study (NCT07306663) | Jiangsu Cancer Institute & Hospital | 2021-06-01 |
| CPAP or BiPAP for Motion Mitigation During Radiotherapy (NCT04986293) | University Medical Center Groningen | 2021-06-01 |
| Endoscopic Assisted Calcium Electroporation in Esophageal Cancer (NCT04958044) | Michael Patrick Achiam | 2021-05-25 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy (NCT04892849) | University of Erlangen-Nürnberg Medical School | 2021-04-30 |
| Prehabilitation and Rehabilitation for Patients With Oesophageal Cancer (NCT04894149) | Gabriella Alexandersson von Döbeln | 2021-04-22 |
| Early Detection of Barrett's Esophagus in Participants With Reflux Symptoms in Primary Care (NCT04656392) | Radboud University Medical Center | 2021-04-20 |
| PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine (NCT05697198) | Labcorp Corporation of America Holdings, Inc | 2021-04-19 |
| Fluorescence Image Guided Foregut Surgery (NCT04734821) | IHU Strasbourg | 2021-04-01 |
| DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) (NCT04825834) | Delfi Diagnostics Inc. | 2021-03-22 |
| A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies (NCT04772989) | Arcus Biosciences, Inc. | 2021-03-19 |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers (NCT04464967) | NKGen Biotech, Inc. | 2021-03-01 |
| Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal Tissues (NCT04804410) | University of Maryland, Baltimore | 2021-03-01 |
| Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection (NCT05499195) | Chinese Academy of Medical Sciences | 2021-03-01 |
| Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus (NCT05846971) | Capsulomics, Inc. | 2021-01-26 |
| Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer (NCT04415853) | Sunshine Lake Pharma Co., Ltd. | 2021-01-21 |
| Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers (NCT04072393) | Washington University School of Medicine | 2021-01-15 |
| Submucosal Saline Injection Followed by Endoscopic Ultrasound (NCT06022978) | Sun Yat-sen University | 2021-01-01 |
| Esophageal Squamous Cell Cancer Surveillance With Cytosponge (NCT04192695) | Centre of Postgraduate Medical Education | 2021-01-01 |
| Esophageal cAncer Screening Trial (NCT04609813) | Changhai Hospital | 2021-01-01 |
| A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer (NCT04822103) | Guangdong Provincial People's Hospital | 2021-01-01 |
| Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors (NCT03740256) | Baylor College of Medicine | 2020-12-14 |
| Conventional Oral Intake vs Delayed Oral Intake With Jejunostomy Feeding After Esophagectomy (JNS Study) (NCT05318404) | Seoul National University Hospital | 2020-12-08 |
| A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal Cancer (NCT04616040) | Peking University | 2020-12-01 |
| A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. (NCT04460066) | Lee's Pharmaceutical Limited | 2020-11-18 |
| Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers (NCT05431621) | Shanghai Zhongshan Hospital | 2020-11-15 |
| Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy . (NCT04652180) | Hospital Universitari de Bellvitge | 2020-11-06 |
| A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma (NCT04540211) | Hoffmann-La Roche | 2020-10-30 |
| Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy (NCT04526886) | Dartmouth-Hitchcock Medical Center | 2020-10-15 |
| Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus (NCT05056051) | Northwestern University | 2020-10-01 |
| Esophagectomy in Patients With Liver Cirrhosis (NCT04809870) | Universitätsklinikum Hamburg-Eppendorf | 2020-10-01 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors (NCT04383210) | Elevation Oncology | 2020-09-29 |
| Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer (NCT04566367) | Georg Dultz | 2020-09-22 |
| The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in Esophagectomy (NCT04615806) | Fujian Medical University Union Hospital | 2020-09-22 |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC (NCT04140526) | OncoC4, Inc. | 2020-09-16 |
| PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy (NCT04494009) | Asan Medical Center | 2020-09-07 |
| Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab (NCT04164069) | Anne Noonan | 2020-09-02 |
| A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer (NCT04512417) | Zhejiang Cancer Hospital | 2020-08-31 |
| Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care (NCT04675138) | National University Hospital, Singapore | 2020-08-20 |
| Total Intravenous Anesthesia and Recurrence Free Survival (NCT04513808) | The Cleveland Clinic | 2020-08-15 |
| A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection (NCT04510285) | Memorial Sloan Kettering Cancer Center | 2020-08-10 |